UY37198A - Vacuna universal para enfermedades virales - Google Patents

Vacuna universal para enfermedades virales

Info

Publication number
UY37198A
UY37198A UY0001037198A UY37198A UY37198A UY 37198 A UY37198 A UY 37198A UY 0001037198 A UY0001037198 A UY 0001037198A UY 37198 A UY37198 A UY 37198A UY 37198 A UY37198 A UY 37198A
Authority
UY
Uruguay
Prior art keywords
polypeptides
proteins
peptides
viral
viral peptides
Prior art date
Application number
UY0001037198A
Other languages
English (en)
Inventor
Rodolfo César Bellinzoni
Emmanuel Gérard Etienne Regulier
Ana Romo
Original Assignee
Biogénesis Bagó Uruguay S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogénesis Bagó Uruguay S A filed Critical Biogénesis Bagó Uruguay S A
Publication of UY37198A publication Critical patent/UY37198A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/135—Foot- and mouth-disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a una combinación farmacéutica para inducir protección cruzada contra múltiples cepas o serotipos de un virus. Esta vacuna universal comprende un partículas virales inactivadas con uno o más de los siguientes componentes: polinucleótidos que codifican péptidos, polipéptidos o proteínas virales en diferentes tipos de plásmidos; péptidos, polipéptidos y proteínas virales; péptidos y polipéptidos virales sintéticos; péptidos, polipéptidos y proteínas virales recombinantes; VLPs; VLPs derivadas de otros virus; proteínas usadas como carrier o como adyuvante molecular fusionadas a péptidos, polipéptidos y/o proteínas derivadas de virus; adyuvantes; emulsionantes, adyuvantes moleculares y sistemas carrier.
UY0001037198A 2016-04-11 2017-04-07 Vacuna universal para enfermedades virales UY37198A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662320852P 2016-04-11 2016-04-11

Publications (1)

Publication Number Publication Date
UY37198A true UY37198A (es) 2017-11-30

Family

ID=60041433

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001037198A UY37198A (es) 2016-04-11 2017-04-07 Vacuna universal para enfermedades virales

Country Status (9)

Country Link
US (2) US10940196B2 (es)
EP (1) EP3443097A4 (es)
KR (1) KR20180132742A (es)
CN (1) CN109196104B (es)
AR (1) AR108014A1 (es)
BR (1) BR112018070634A2 (es)
TW (1) TWI763662B (es)
UY (1) UY37198A (es)
WO (1) WO2017178945A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3909970A1 (en) * 2020-05-14 2021-11-17 Consejo Superior De Investigaciones Científicas Peptide vaccines for the prevention of foot-and-mouth disease
CN111744000B (zh) * 2020-07-14 2021-03-23 中国农业科学院兰州兽医研究所 免疫抑制功能降低的口蹄疫重组病毒及其制备方法与应用
CN111978380A (zh) * 2020-09-02 2020-11-24 天康生物股份有限公司 野生型气肿疽梭菌细胞毒素a及其制备方法、应用和疫苗
CN114748617B (zh) * 2022-03-24 2024-04-16 华南农业大学 一种大口黑鲈虹彩病毒的亚单位疫苗及其制备方法和应用
CN114874338B (zh) * 2022-05-18 2024-04-12 华中农业大学 一种口蹄疫病毒纳米颗粒及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1245217C (zh) * 2001-02-15 2006-03-15 雷吉斯特印度科学院 一种包含dna疫苗和灭活狂犬病毒的疫苗制剂
CN1408434A (zh) * 2002-09-16 2003-04-09 复旦大学 抗家畜口蹄疫的多肽和dna联合疫苗及其制备方法
AR044603A1 (es) * 2004-06-03 2005-09-21 Consejo Nac Invest Cient Tec Proteinas quimericas aisladas de lumazina sintetasa modificada para la presentacion multiple de moleculas y sus aplicaciones
CN106987595B (zh) * 2009-11-02 2021-07-06 宾夕法尼亚大学托管会 口蹄疫病毒病毒(fmdv)共有蛋白质、其编码序列及由其制备的疫苗
CN101948811B (zh) * 2010-08-18 2013-01-09 中国农业科学院兰州兽医研究所 用反向遗传操作拓展口蹄疫疫苗株抗原谱及疫苗制备方法
CN102168088B (zh) * 2010-12-23 2012-12-26 中国农业科学院兰州兽医研究所 T细胞免疫原基因ti及其在口蹄疫蛋白亚单位疫苗和灭活疫苗中的应用
MX2015011931A (es) 2013-03-15 2016-04-07 Novavax Inc Expresion mejorada de proteinas de picornavirus.
MX368441B (es) * 2013-05-27 2019-10-02 Inmunova S A Quimeras de lumazina sintasa de brucella y la subunidad beta de toxinas ab5.
CN105056227B (zh) 2015-07-21 2017-12-29 复旦大学 一种抗口蹄疫病毒的类病毒粒子vlp疫苗及其制备方法

Also Published As

Publication number Publication date
US10940196B2 (en) 2021-03-09
TW201740973A (zh) 2017-12-01
US20210187096A1 (en) 2021-06-24
AR108014A1 (es) 2018-07-11
CN109196104A (zh) 2019-01-11
EP3443097A1 (en) 2019-02-20
KR20180132742A (ko) 2018-12-12
CN109196104B (zh) 2023-01-31
US20190142926A1 (en) 2019-05-16
BR112018070634A2 (pt) 2019-02-05
EP3443097A4 (en) 2020-04-22
TWI763662B (zh) 2022-05-11
WO2017178945A1 (en) 2017-10-19

Similar Documents

Publication Publication Date Title
UY37198A (es) Vacuna universal para enfermedades virales
CY1124254T1 (el) Μεθοδοι και συνθεσεις για την προκληση προστατευτικης ανοσιας εναντι λοιμωξης ιου της ανθρωπινης ανοσοανεπαρκειας
MX2021006931A (es) Antigenos del virus de la inmunodeficiencia humana, vectores, composiciones y metodos de uso de estos.
CL2018000740A1 (es) Vectores del factor viii del virus adeno-asociado, partículas víricas asociadas y formulaciones terapéuticas que los comprenden
CO2018007203A2 (es) Focalización de péptidos para dirigir virus adenoasociados (aavs)
BR112016007868A2 (pt) vacinas contra o vírus de epstein-barr
BR112018075032A2 (pt) proteínas de hemaglutinina do vírus influenza e seus uso
CU24580B1 (es) Vectores atenuados de influenza para la prevención y/o tratamiento de enfermedades infecciosas y para el tratamiento de enfermedades oncológicas
MY191322A (en) Recombinant vectors expressing antigens of avian influenza virus and uses thereof
AR101814A1 (es) Partícula de tipo virus flavivirus
PH12020500569A1 (en) Influenza virus vaccines and uses thereof
NZ739260A (en) Inactivated canine influenza vaccines and methods of making and uses thereof
EA201890042A1 (ru) Вакцина против вируса ящура (вя) на основе рекомбинантного модифицированного вируса осповакцины анкара (mva)
MY179251A (en) Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development
PE20170429A1 (es) Vacuna en vector recombinante de adenovirus aviar serotipo 9
PH12018502436A1 (en) Multivalent vaccines major swine viral diseases
PH12017500419A1 (en) Recoded arbovirus and vaccines
AR095425A1 (es) Vacuna, uso y procedimiento para prevenir una infección por picornavirus
BR112018015912A2 (pt) vírus da vacina da síndrome respiratória e reprodutiva porcina
CL2019000405A1 (es) Vacunas virales.
EP3599247A3 (en) Recombinant hemagglutinin protein of influenza virus and vaccine containing the same
MX2019007924A (es) Vacunas contra la influenza.
BR112017024786A2 (pt) virus oncolíticos recombinantes e usos dos mesmos
MX360137B (es) Proteínas h5 del virus de la influenza h5n1 para usarse como un medicamento.
BR112019008584A2 (pt) vacinas de mosaico para vírus de doença de pé-e-boca de sorotipo a

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20231110